Steve R. Zeldenrust
- Molecular Biology top 10%
- Nephrology top 2%
- Genetics top 5%
- Oncology top 10%
- Hematology top 5%
- Co-authors
- Angela DispenzieriNelson LeungMorie A. GertzRobert A. KyleSuzanne R. HaymanShaji KumarS. Vincent RajkumarMartha Q. Lacy
- Topics
- Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers)Neuroendocrine Tumor Research Advances (3 papers)Pneumocystis jirovecii pneumonia detection and treatment (2 papers)
- Cited by
- NephrologyGeneticsHematology
- Partner nations
- United StatesIsrael
In The Last Decade
Steve R. Zeldenrust
9 papers receiving 987 citations
Hit Papers
Peers
Comparison fields: 5 of 45
- Molecular Biology 949
- Nephrology 312
- Genetics 265
- Oncology 239
- Hematology 196
Countries citing papers authored by Steve R. Zeldenrust
This map shows the geographic impact of Steve R. Zeldenrust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve R. Zeldenrust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve R. Zeldenrust more than expected).
Fields of papers citing papers by Steve R. Zeldenrust
This network shows the impact of papers produced by Steve R. Zeldenrust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve R. Zeldenrust. The network helps show where Steve R. Zeldenrust may publish in the future.
Co-authorship network of co-authors of Steve R. Zeldenrust
This figure shows the co-authorship network connecting the top 25 collaborators of Steve R. Zeldenrust. A scholar is included among the top collaborators of Steve R. Zeldenrust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve R. Zeldenrust. Steve R. Zeldenrust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 13 | |
| 3 | 55 | |
| 4 | Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurementsbreakdown → | 730 |
| 5 | 121 | |
| 6 | 21 | |
| 7 | 37 | |
| 8 | 1 | |
| 9 | 2 |
About Steve R. Zeldenrust
Steve R. Zeldenrust is a scholar working on Nephrology, Genetics and Hematology, having authored 9 papers that have together received 1000 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Neuroendocrine Tumor Research Advances (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Nephrology (312 citations), Genetics (265 citations) and Hematology (196 citations). Steve R. Zeldenrust has collaborated with scholars based in United States and Israel. Frequent co-authors include Angela Dispenzieri, Nelson Leung, Morie A. Gertz, Robert A. Kyle, Suzanne R. Hayman, Shaji Kumar, S. Vincent Rajkumar, Martha Q. Lacy, Francis K. Buadi and Colin Colby. Their work appears in journals such as Journal of Clinical Oncology, Blood and Mayo Clinic Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.